Updated Date:
30 Sep 2026
Product Detail:
BICILLIN L-A benzathine benzylpenicillin tetrahydrate 1,200,000 Units / 2.3 mL suspension for injection pre-filled syringe with needle
Shortage Status:
Current
AUST R:
147169
Availability:
Unavailable
Active Ingredient:
benzathine benzylpenicillin tetrahydrate
Reason:
Manufacturing
Dosage Form:
Injection,suspension
Supply Impact Dates
From 22 Apr 2025
To 31 Mar 2027
Management Action:
Health professionals are encouraged to consider reserving any remaining Australian-registered Bicillin L-A stock held within their services for paediatric patients. Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. The TGA has published a web statement outlining key information about the shortage which is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-bicillin-l-benzathine-benzylpenicillin-tetrahydrate-prefilled-syringe-injection